LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Md. Anisul Islam

Md. Anisul Islam

LiveDNA ID: 880.46867
1 Publications
0 Editorial Roles
0 Projects

About

Professional Summary

I am a registered pharmacist, Product Manager at BrightBrain AI Ltd., and Quality Assurance professional with expertise spanning pharmaceutical sciences, artificial intelligence, and computational drug discovery. My research focuses on computer-aided drug discovery, bioinformatics, molecular docking, molecular dynamics simulation, network pharmacology, virtual screening, ADMET prediction, drug repurposing, and natural product-based drug discovery. I have extensive experience in pharmaceutical quality systems, Good Manufacturing Practices (GMP), regulatory compliance, and analytical laboratory operations. As a Product Manager, I lead the planning, development, and optimization of AI-driven digital products, collaborating with cross-functional teams to deliver innovative and user-centered solutions. My research integrates in vitro, in vivo, and in silico approaches to identify and evaluate therapeutic candidates for cancer, neurological disorders, inflammation, diabetes, and cardiovascular diseases. I am committed to advancing translational research by combining pharmaceutical sciences, bioinformatics, and artificial intelligence to accelerate modern drug discovery and improve healthcare outcomes.

Education

Academic Background
  • B. Pharm. BGC Trust University, Bangladesh Pharmacy | Completed: 2022

Publications (1)

Selected Scholarly Contributions
Anti-Inflammatory, Analgesic and Anti-Oxidant Effects of Shirakiopsis Indica (Willd). Fruit Extract: A Mangrove Species in the Field of Inflammation Research
Pair Jiko, Mahathir Mohammad, Fahmida Tasnim Richi, Md. Anisul Islam, Safaet Alam, Mohammad Abdullah Taher, Chuxiao Shao, Shuanghu Wang, Peiwu Geng, Abdullah Al Mamun
Journal of Inflammation Research | Journal Article
Crossref
2024